The Trusted Voice of Fund Trustees

06:04 PM, Jul. 31, 2010
DOWNLOAD CURRENT ISSUE (PDF)
CORPORATE ACCESS
CONTACT US
SUBSCRIBE NOW
FREE TRIAL
Skip Navigation Links
NEWS
Home
Governance
Regulatory Update
Industry Groups
Bulletin Board
FEATURES
How Boards Work
Conferences
Q&A
Trustee Profiles
Learning Curve
Special Reports
Awards
RESOURCES
Archives
Links
Buyer's GuidesExpand Buyer's Guides
Rising StarsExpand Rising Stars
Events
Securities Technology Product & Services Online Guide
Hedge Fund Service Provider Guide
Pension Fund Service Provider Guide
Structured Finance Service Provider Guide
Scroll up
Scroll down
2010 Rising Stars of Public Funds
2009 Rising Stars of Hedge Funds
2009 Rising Stars of Foundations and Endowments
2009 Rising Stars of Mutual Funds
2009 Rising Stars of Public Funds
Scroll up
Scroll down
PRODUCTS & SERVICES
RSS Feeds
Corporate Access
Reprints
Career Center

Skip Navigation Links
CUSTOMER SERVICE
Agents
About Fund Directions
Contact Us
Help/FAQ's
ADVERTISING
Advertising Opportunities
SUBSCRIBE
Subscribe
Free Trial

Donohue Hits Some Takeover Defenses





 



 Andrew Donohue Closed-end fund boards need to be careful when employing certain tactics to fend off dissident shareholders, Andrew "Buddy" Donohue, director of the Securities and Exchange Commission's Division of Investment Management warned at a meeting of the Independent Directors Council last month. He cited several techniques to thwart takeovers that raised governance issues, even though they are permitted by state law.

Most notably, Donohue said the use of poison pill defenses, which put restrictions on the voting shares of dissident shareholders, raises questions under provisions of the Investment Company Act of 1940. "I submit that the adoption of a poison pill, or restricting the voting rights of a 'dissident' shareholder even where state law authorizes it, may be inconsistent with ...

To read this article, please subscribe or take a free trial.
Subscribe

Subscribers have unlimited access to all current content, email alerts and breaking news. Start your subscription today - click on the button below.

Subscribe

Free Trial

Taking a free trial will give you access to the current issue, email alerts and breaking news for a limited period. Start your free trial today.

Free Trial

Already Have An Account?

Username:
 Password:
Fund Directions | DOWNLOAD CURRENT ISSUE (PDF) | Corporate Access | Contact Us | Subscribe | Free Trial | Sitemap
© 2010 Institutional Investor | Terms & Conditions | Privacy Policy